Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 11;8(9):e75388.
doi: 10.1371/journal.pone.0075388. eCollection 2013.

Expression of angiopoietin-2 and vascular endothelial growth factor receptor-3 correlates with lymphangiogenesis and angiogenesis and affects survival of oral squamous cell carcinoma

Affiliations

Expression of angiopoietin-2 and vascular endothelial growth factor receptor-3 correlates with lymphangiogenesis and angiogenesis and affects survival of oral squamous cell carcinoma

Chao Li et al. PLoS One. .

Abstract

Background: Both Ang-2 and VEGFR-3 are major regulators of angiogenesis and lymphangiogenesis, respectively, and thus may affect prognosis of OSCC. We sought to determine the associations between Ang-2 and VEGFR-3 expression and survival of OSCC.

Methods: Ang-2 and VEGFR-3 expression was determined immunohistochemically in tumor tissues from 112 patients with OSCC; OSCC-adjacent noncancerous oral tissue from 85 OSCC patients; and normal oral mucosa from 37 cancer-free individuals. A log-rank test and Cox proportional hazard models were used to compare survival among different groups with expression of Ang-2 and VEGFR-3.

Results: Ang-2 and VEGFR-3 expression was upregulated in OSCC compared to nontumor tissue (all P<0.05). High Ang-2 expression positively correlated with microvessel density (MVD) (P<0.01), and high VEGFR-3 expression positively correlated with lymph node metastasis (P<0.01) and lymphatic vessel density (LVD) (P<0.01). The patients with high expression of Ang-2 alone or in combination with VEGFR-3 had a significantly worse survival than in patients with low expression of Ang-2 or any other co-expression status (all P<0.05), respectively. Furthermore, multivariable analysis showed that patients with high expression of Ang-2 alone or in combination with VEGFR-3 had a significantly increased risk of death compared with those with low expression of Ang-2 or any other co-expression status (HR, 2.7, 95% CI, 1.1-6.2 and 5.0, 1.3-15.4, respectively).

Conclusions: These results suggest that increased expression in tumors of Ang-2 may individually, or in combination with VEGFR-3, predict poor prognosis of OSCC.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Immunohistochemical expression of Ang-2 and VEGFR-3 in OSCC (streptavidin/avidin-biotin complex ×400) (A) and CD34 (scarlet; blood vessels) and D2-40 (purple-black; lymphatic vessels) in OSCC and normal oral mucosa (streptavidin/avidin-biotin comple double-labeling ×400) (B).
Figure 2
Figure 2. Rates of expression of Ang-2 and VEGFR-3 in OSCC and normal control tissues.
Figure 3
Figure 3. Correlation between Ang-2 and VEGFR-3 status with MVD (A) and LVD (B).
Figure 4
Figure 4. Kaplan-Meier survival for OSCC patients by Ang-2 (A) and VEGFR-3 (B) status.
Figure 5
Figure 5. Kaplan-Meier survival for OSCC patients by combined Ang-2 and VEGFR-3 status.

Similar articles

Cited by

References

    1. Massano J, Regateiro FS, Januário G, Ferreira A (2006) Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102: 67–76. - PubMed
    1. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, et al. (2002) Ang-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by ang-1. Dev Cell 3: 411–423. - PubMed
    1. C Li, HC Feng, YF Song (2005) Expression of Angiopoietin-2 and Vascular Endothelial Growth Factor in Oral Squamous Cell Carcinoma and Its Significance. The Chin-Germ J of Clin oncol 4: 232–237.
    1. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K (2004) Lymphaticvasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25: 387–395. - PubMed
    1. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17: 1471–1474. - PubMed

Publication types

MeSH terms

Substances